U.S. Rep. Alexandria Ocasio-Cortez (D-NY), whose district includes parts of the Bronx and Queens, is leading a congressional ...

A hearing this week marked a critical juncture in the national conversation about the intersection of biotechnology, privacy, ...

The bankruptcy of genetic testing service 23andme Holding Corp. prompted a reaction from many quarters, but a June 11 Senate ...

Below, check out the roundup of California Healthline’s coverage. For today's national health news, read KFF Health News’ Morning Briefing.

The future of the genetic data owned by 23andMe is uncertain as the company undergoes a court-supervised sale.

27 states and D.C. sue to block 23andMe's data sale amid bankruptcy proceedings. Regeneron Pharmaceuticals' $256 million acquisition faces scrutiny over privacy concerns. Court-appointed privacy ...

Me’s interim chief executive Joseph Selsavage told lawmakers on Tuesday that 1.9 million people, or about 15% of its customer ...

State attorneys general are seeking a ruling in 23andMe’s bankruptcy that the DNA testing firm needs explicit consent from customers before transferring their genetic data to another company.

Three years after litigation started over technology used in Comirnaty, the mRNA vaccine for COVID-19, Biontech SE is acquiring its adversary, Curevac NV, through an all-stock transaction valued at ...

Twenty-seven states and the District of Columbia have filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer consent.